Drug discovery is a process wherein new drugs are identified for any disease indication. Developing drug from the stage of discovery to market approval is a lengthy process which contribute to significant costs to the developers. Main focus of R&D is into identification of a target and discovery of some chemical candidates which can activate or block the target. The main reasons of drug failure are lack of efficacy and safety of discovered drug candidate, leading to financial losses to the companies. To inhibit such contingencies, the status of efficient drug discovery process have become critical in the field of drug development.
Major market drivers of drug discovery is globally expanding population, rising prevalence of diverse range of disease encompassing neurology, cardiovascular, oncology and other chronic disease areas. Some tropical infectious diseases are still in need of appropriate medical interventions. Pharmaceutical solutions are required to meet this challenge and also to overcome severe issues like antibiotic resistance. Number of ways are identified and being explored to strengthen the drug discovery technologies market in future years by facilitating patented innovation in free access platform, developing new metrices for capturing data of open research and reforming regulatory guidelines by assigning particular designation for products. Increasing research funding from governmental organizations and pharmaceutical manufacturers and patent expiration of marketed drugs are the major reasons behind the smooth progress of drug discovery technologies market worldwide. Introduction of new technologies is expected to escalate the market growth in coming years by efficiently identifying promising drug candidates and reducing the chances of failure.
Utilizing advanced tools such as text mining and machine learning to streamline the course of finding and developing new drug is predicted to boost the future drug discovery technologies market. The adoption of artificial intelligence tool and IT solution in drug discovery for speeding up research process is likely to influence overall drug discovery technologies market growth and industry landscape. However, overall huge expenses of drug discovery, delayed processing of stringent government regulations act as restraining factors to the market growth.
The purpose of this research study titled Drug Discovery Technologies Market - Growth, Future Prospects, and Competitive Analysis, 2022 - 2030 is to provide investors, developers, industry experts, company executives and with exhaustive analysis to enable them to take vital strategic initiatives and decisions related to the prospects in the global drug discovery technologies market. This report encompasses key market dynamic factors of drug discovery such as driving forces, restraining factors, and major opportunities. This research report also delivers the predominant and future trends in the drug discovery technologies market which is projected through 2030 along with CAGR for the period of 2022-2030.
This report categorizes the global drug discovery technologies market in terms of technology type and geographical distribution. On the basis of drug discovery technologies type, the market has been segmented into high throughput screening, biochips, bioinformatics, pharmacogenomics and pharmacogenetics, combinatorial chemistry, nanotechnology, spectroscopy, metabolomics and others (RNAi, proteomics, epigenetics, and chromatography). This research report offered cross-sectional analysis of each and every segment with base year (2020) data to gain better understanding of the market and forecasted through 2029 with CAGR considering 2022-2030.
This report includes detailed profiling of major players of drug discovery technologies market with thorough explanation of competitive assessment tools like major agreements, acquisition and merger activities, partnerships and collaborations, market attractiveness assessment and competitive landscape analysis. The major players profiled in this report are Abbott Laboratories, Inc., Novartis AG, Eli Lily, Affymetrix Inc, AstraZeneca plc., Boehringer Ingelheim, Inc., Bayer Healthcare AG, GlaxoSmithKline LLC., Pfizer Inc., Sanofi, Albany Molecular Research Inc., and Luminex Corporation.
High throughput screening (HTS) is the leading segment of drug discovery technologies market. The increasing popularity of HTS is due to its high throughput, higher efficiency, rapid assessment of the biological activity of any drug-like compound and identification of ligand for pharmacological targets. However, the expensive screening process and requirement of specialized laboratory might act as challenging factors for the market. Increasing adoption of biochip technology in drug discovery with the objective of speeding up the drug discovery process, cutting down the attrition rate and minimizing the timeline of pipeline drugs. Advancement in biochip with increasing flexibility of array technology opened up the door of immense opportunity for drug discovery. Bioinformatics technology has been driving the drug discovery market by accelerating drug target identification, screening drug candidate, anticipating drug resistance and characterizing probable side-effects. Expanding pressure to produce huge number of drugs in a brief timeframe with minimal risk has brought about intense interest in bioinformatics. Presently, the demand for artificial intelligence platforms is on rise, as they enable researchers to effectively identify drug target or screen drug repositioning, which further is expected to stimulate the drug discovery technologies market growth. Nanotechnology is playing a stellar role in drug discovery technologies market by developing enhanced drug formulations, drug delivery systems, while overcoming challenges like inadequate throughput and unreliable data.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
Major market drivers of drug discovery is globally expanding population, rising prevalence of diverse range of disease encompassing neurology, cardiovascular, oncology and other chronic disease areas. Some tropical infectious diseases are still in need of appropriate medical interventions. Pharmaceutical solutions are required to meet this challenge and also to overcome severe issues like antibiotic resistance. Number of ways are identified and being explored to strengthen the drug discovery technologies market in future years by facilitating patented innovation in free access platform, developing new metrices for capturing data of open research and reforming regulatory guidelines by assigning particular designation for products. Increasing research funding from governmental organizations and pharmaceutical manufacturers and patent expiration of marketed drugs are the major reasons behind the smooth progress of drug discovery technologies market worldwide. Introduction of new technologies is expected to escalate the market growth in coming years by efficiently identifying promising drug candidates and reducing the chances of failure.
Utilizing advanced tools such as text mining and machine learning to streamline the course of finding and developing new drug is predicted to boost the future drug discovery technologies market. The adoption of artificial intelligence tool and IT solution in drug discovery for speeding up research process is likely to influence overall drug discovery technologies market growth and industry landscape. However, overall huge expenses of drug discovery, delayed processing of stringent government regulations act as restraining factors to the market growth.
The purpose of this research study titled Drug Discovery Technologies Market - Growth, Future Prospects, and Competitive Analysis, 2022 - 2030 is to provide investors, developers, industry experts, company executives and with exhaustive analysis to enable them to take vital strategic initiatives and decisions related to the prospects in the global drug discovery technologies market. This report encompasses key market dynamic factors of drug discovery such as driving forces, restraining factors, and major opportunities. This research report also delivers the predominant and future trends in the drug discovery technologies market which is projected through 2030 along with CAGR for the period of 2022-2030.
This report categorizes the global drug discovery technologies market in terms of technology type and geographical distribution. On the basis of drug discovery technologies type, the market has been segmented into high throughput screening, biochips, bioinformatics, pharmacogenomics and pharmacogenetics, combinatorial chemistry, nanotechnology, spectroscopy, metabolomics and others (RNAi, proteomics, epigenetics, and chromatography). This research report offered cross-sectional analysis of each and every segment with base year (2020) data to gain better understanding of the market and forecasted through 2029 with CAGR considering 2022-2030.
This report includes detailed profiling of major players of drug discovery technologies market with thorough explanation of competitive assessment tools like major agreements, acquisition and merger activities, partnerships and collaborations, market attractiveness assessment and competitive landscape analysis. The major players profiled in this report are Abbott Laboratories, Inc., Novartis AG, Eli Lily, Affymetrix Inc, AstraZeneca plc., Boehringer Ingelheim, Inc., Bayer Healthcare AG, GlaxoSmithKline LLC., Pfizer Inc., Sanofi, Albany Molecular Research Inc., and Luminex Corporation.
High throughput screening (HTS) is the leading segment of drug discovery technologies market. The increasing popularity of HTS is due to its high throughput, higher efficiency, rapid assessment of the biological activity of any drug-like compound and identification of ligand for pharmacological targets. However, the expensive screening process and requirement of specialized laboratory might act as challenging factors for the market. Increasing adoption of biochip technology in drug discovery with the objective of speeding up the drug discovery process, cutting down the attrition rate and minimizing the timeline of pipeline drugs. Advancement in biochip with increasing flexibility of array technology opened up the door of immense opportunity for drug discovery. Bioinformatics technology has been driving the drug discovery market by accelerating drug target identification, screening drug candidate, anticipating drug resistance and characterizing probable side-effects. Expanding pressure to produce huge number of drugs in a brief timeframe with minimal risk has brought about intense interest in bioinformatics. Presently, the demand for artificial intelligence platforms is on rise, as they enable researchers to effectively identify drug target or screen drug repositioning, which further is expected to stimulate the drug discovery technologies market growth. Nanotechnology is playing a stellar role in drug discovery technologies market by developing enhanced drug formulations, drug delivery systems, while overcoming challenges like inadequate throughput and unreliable data.
Geographically, the global drug discovery technologies market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
In the base year 2021, North America is estimated to be the most significant market for drug discovery technologies as the region is the hub of all major drug manufacturing companies. The adoption of recent advanced technologies is higher in North America, which in turn acts as driving force of the market growth. Increasing expenditure on R&D and promising policies encourage pharmaceutical companies to develop drugs. The United States being the leader in medical research produced more than half of drug molecules in the last decade. Launching of the fast-track scheme for drug approval, PRIME initiative by the European Medicine Agency is expected to augment drug discovery technologies market in this region. Increasing initiatives for collaborative research projects and networking among industrial and academic experts, large pharmaceutical companies and medium or small sized enterprises are expected to support pharmaceutical development in Europe. European Lead Factory is a platform aiming to escalate drug discovery in Europe by providing access to academic institutions, small and medium enterprises with more than 500,000 novel chemical compounds and boost the drug discovery activities. Asia Pacific is a region of 60% of the world's population. This region is expected to witness substantial growth due to the large targeted population as it offers a pool of potential clinical trials. Rising disease prevalence, increasing funding for research activities and improved regulatory guidelines regarding the clinical research are few of the major drivers of the drug discovery technologies market in Asia Pacific.Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Drug Discovery Technologies market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Drug Discovery Technologies market and their expected impact during the forecast period.
Market Segmentation
Type
- High Throughput Screening
- Biochips
- Bioinformatics
- Pharmacogenomics and Pharmacogenetics
- Combinatorial Chemistry
- Nanotechnology
- Spectroscopy
- Metabolomics
- Others (RNAi, Proteomics, Epigenetics, Chromatography)
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Drug Discovery Technologies market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2030.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Drug Discovery Technologies market?
- Which is the largest regional market for Drug Discovery Technologies market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Drug Discovery Technologies market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Drug Discovery Technologies market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Drug Discovery Technologies Market
2.2. Global Drug Discovery Technologies Market, By Type, 2021 (US$ Million)
2.3. Global Drug Discovery Technologies Market, By Geography, 2021 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2021
3. Drug Discovery Technologies Market: Competitive Analysis
3.1. Market Positioning of Key Drug Discovery Technologies Market Vendors
3.2. Strategies Adopted by Drug Discovery Technologies Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2021 Versus 2030
4. Drug Discovery Technologies Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Drug Discovery Technologies Market Value, 2020 - 2030, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. High Throughput Screening
5.3.2. Biochips
5.3.3. Bioinformatics
5.3.4. Pharmacogenomics and Pharmacogenetics
5.3.5. Combinatorial Chemistry
5.3.6. Nanotechnology
5.3.7. Spectroscopy
5.3.8. Metabolomics
5.3.9. Others (RNAi, Proteomics, Epigenetics, Chromatography)
6. North America Drug Discovery Technologies Market, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
6.3.Drug Discovery Technologies Market: By Region, 2020-2030, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
7. UK and European Union Drug Discovery Technologies Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
7.3.Drug Discovery Technologies Market: By Region, 2020-2030, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
7.3.1.5. France
7.3.1.5.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
8. Asia Pacific Drug Discovery Technologies Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
8.3.Drug Discovery Technologies Market: By Region, 2020-2030, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
8.3.1.3. India
8.3.1.3.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
9. Latin America Drug Discovery Technologies Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
9.3.Drug Discovery Technologies Market: By Region, 2020-2030, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
10. Middle East and Africa Drug Discovery Technologies Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
10.3.Drug Discovery Technologies Market: By Region, 2020-2030, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Drug Discovery Technologies Market: By Type, 2020-2030, USD (Million)
11. Company Profile
11.1. Abbott Laboratories, Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Affymetrix Inc.
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Albany Molecular Research Inc.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. AstraZeneca plc.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Bayer Healthcare AG
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Boehringer Ingelheim, Inc.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. Eli Lily
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. GlaxoSmithKline LLC.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Luminex Corporation
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Novartis AG
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives
11.11. Pfizer Inc.
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Portfolio
11.11.4. Strategic Initiatives
11.12. Sanofi
11.12.1. Company Overview
11.12.2. Financial Performance
11.12.3. Product Portfolio
11.12.4. Strategic Initiatives
List of Figures
Figure 1 Global Drug Discovery Technologies Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Drug Discovery Technologies Market: Quality Assurance
Figure 5 Global Drug Discovery Technologies Market, By Type, 2021
Figure 6 Global Drug Discovery Technologies Market, By Geography, 2021
Figure 7 Market Geographical Opportunity Matrix - Global Drug Discovery Technologies Market, 2021
Figure 8 Market Positioning of Key Drug Discovery Technologies Market Players, 2021
Figure 9 Global Drug Discovery Technologies Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 10 Global Drug Discovery Technologies Market, By Type, 2021 Vs 2030, %
Figure 11 U.S. Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 12 Canada Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 13 Rest of North America Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 14 UK Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 15 Germany Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 16 Spain Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 17 Italy Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 18 France Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 19 Rest of Europe Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 20 China Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 21 Japan Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 22 India Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 23 Australia Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 24 South Korea Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 25 Rest of Asia Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 26 Brazil Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 27 Mexico Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 28 Rest of Latin America Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 29 GCC Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 30 Africa Drug Discovery Technologies Market (US$ Million), 2020 - 2030
Figure 31 Rest of Middle East and Africa Drug Discovery Technologies Market (US$ Million), 2020 - 2030
List of Tables
Table 1 Global Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 2 North America Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 3 U.S. Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 4 Canada Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 5 Rest of North America Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 6 UK and European Union Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 7 UK Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 8 Germany Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 9 Spain Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 10 Italy Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 11 France Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 12 Rest of Europe Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 13 Asia Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 14 China Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 15 Japan Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 16 India Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 17 Australia Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 18 South Korea Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 19 Latin America Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 20 Brazil Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 21 Mexico Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 22 Rest of Latin America Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 23 Middle East and Africa Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 24 GCC Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 25 Africa Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Table 26 Rest of Middle East and Africa Drug Discovery Technologies Market By Type, 2020-2030, USD (Million)
Companies Mentioned
- Abbott Laboratories Inc.
- Novartis AG
- Eli Lily
- Affymetrix Inc
- AstraZeneca plc.
- Boehringer Ingelheim Inc.
- Bayer Healthcare AG
- GlaxoSmithKline LLC.
- Pfizer Inc.
- Sanofi
- Albany Molecular Research Inc.
- Luminex Corporation
